Literature DB >> 16966706

Long term suppressive therapy with pegylated interferon for chronic hepatitis C associated membranoproliferative glomerulonephritis.

I H Y Cua, V Kwan, M Henriquez, J Kench, J George.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16966706      PMCID： PMC1856412          DOI： 10.1136/gut.2006.094508

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  8 in total

1.  Peginterferon and dose-titrated ribavirin for hepatitis C-associated nephrotic membranoproliferative glomerulonephritis type 1.

Authors:  Hans Orlent; Ron A Mathot; Eric F Van Bommel; Arnold G Vulto; Solko W Schalm; Johannes T Brouwer
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

2.  Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathy.

Authors:  Alaa A Sabry; Mohamed A Sobh; Hussein A Sheaashaa; Guara Kudesia; Graham Wild; Samantha Fox; Bart E Wagner; William L Irving; Anna Grabowska; Abdel Meguid El-Nahas
Journal:  Nephrol Dial Transplant       Date:  2002-11       Impact factor: 5.992

Review 3.  Treatment of hepatitis C-associated glomerular disease.

Authors:  J A Jefferson; R J Johnson
Journal:  Semin Nephrol       Date:  2000-05       Impact factor: 5.299

4.  Response to high-dose interferon-alpha after failure of standard therapy in MPGN associated with hepatitis C virus infection.

Authors:  E Sarac; S Bastacky; J P Johnson
Journal:  Am J Kidney Dis       Date:  1997-07       Impact factor: 8.860

5.  Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis.

Authors:  G Garini; L Allegri; L Carnevali; W Catellani; P Manganelli; C Buzio
Journal:  Am J Kidney Dis       Date:  2001-12       Impact factor: 8.860

6.  Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency.

Authors:  Annette Bruchfeld; Karin Lindahl; Lars Ståhle; Magnus Söderberg; Robert Schvarcz
Journal:  Nephrol Dial Transplant       Date:  2003-08       Impact factor: 5.992

7.  Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy.

Authors:  Paolo Rossi; Tullio Bertani; Piero Baio; Roberta Caldara; Patrizia Luliri; Francesca Tengattini; Piermario Bellavita; Gianna Mazzucco; Rocco Misiani
Journal:  Kidney Int       Date:  2003-06       Impact factor: 10.612

8.  Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN.

Authors:  Laurent Alric; Emmanuelle Plaisier; Sophie Thébault; Jean-Marie Péron; Lionel Rostaing; Jacques Pourrat; Pierre Ronco; Jean-Charles Piette; Patrice Cacoub
Journal:  Am J Kidney Dis       Date:  2004-04       Impact factor: 8.860
  8 in total
  1 in total

Review 1.  Management of hepatitis C in patients with chronic kidney disease.

Authors:  Mohammad A B Al-Freah; Zeino Zeino; Michael A Heneghan
Journal:  Curr Gastroenterol Rep       Date:  2012-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.